The role of 123I-diagnostic imaging in the follow-up of patients with differentiated thyroid carcinoma as compared to 131I-scanning: Avoidance of negative therapeutic uptake due to stunning

Clinical Endocrinology

Volumn 55, Issue 4, 2001, Pages 515-521

  Siddiqi, A ^a   Foley, R R ^a   Britton, K E ^a   Sibtain, A ^a   Plowman, P N ^a   Grossman, A B ^a   Monson, J P ^a   Besser, G M ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 123; IODINE 131; RADIOISOTOPE; THYROGLOBULIN; TRACER; DIAGNOSTIC AGENT; RADIOACTIVE IODINE;

ADULT; AGED; ARTICLE; BONE METASTASIS; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DRUG EFFECT; DRUG UPTAKE; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; LUNG METASTASIS; MALE; MEDIASTINUM METASTASIS; PRIORITY JOURNAL; RADIATION DOSE; THYROGLOBULIN BLOOD LEVEL; THYROID CARCINOMA; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION; WHOLE BODY SCINTISCANNING; BLOOD; CARCINOMA; COMPARATIVE STUDY; MIDDLE AGED; PAPILLARY CARCINOMA; PREDICTION AND FORECASTING; RADIATION EXPOSURE; SCINTISCANNING; THYROID FOLLICULAR CARCINOMA; THYROID GLAND; THYROID TUMOR; TUMOR RECURRENCE;

ADULT; AGED; CARCINOMA; CARCINOMA, PAPILLARY; CARCINOMA, PAPILLARY, FOLLICULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; THYROGLOBULIN; THYROID GLAND; THYROID NEOPLASMS;

EID: 0034791890     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2001.01376.x     Document Type: Article

References (24)

1. Octreotide scintigraphy in patients with differentiated thyroid carcinoma: Contribution for patients with negative radioiodine scan
2. Serum thyroglobulin measurements in thyroid cancer: Evaluation of false positive results
3. Radioimmunoscintigraphy in tumour identification
4. Where next and how? Highlights lecture
5. Thyroid stunning
6. Imaging of metastases of thyroid carcinoma with F-18 fluorodeoxyglucose
7. The usefulness of serum thyroglobulin in the follow-up of differentiated thyroid carcinoma in children
8. Isolated detectable serum thyroglobulin levels in differentiated thyroid cancer. Interest of therapeutic dose of I-131 in the detection of metastases
9. Decreased uptake of therapeutic doses of I-131 after 185 MBq I-131 diagnostic imaging for thyroid remnants in differentiated thyroid carcinoma
10. Serum thyroglobulin and I-131 whole body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma
11. Dosimetric calculations in the radioiodine treatment of macrometastases and micrometastases from differentiated thyroid cancer
12. Thyrotropin-releasing hormone as a thyroid function test
13. Serum thyroglobulin in the follow-up of patients with differentiated thyroid cancer
14. Therapeutic doses of I-131 reveal undiagnosed metastases in thyroid cancer patients with detectable thyroglobulin levels
15. Serum thyroglobulin determination in thyroid cancer: A ten year experience
16. Influence of diagnostic radioiodine on the uptake of ablative dose of iodine-131
17. Detection of thyroid remnant/metastasis without stunning: An ongoing dilemma
18. I-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan
19. Thallium-201 scintigraphy in differentiated thyroid cancer; comparison with radioiodine scintigraphy and serum thyroglobulin determinations
20. 99m-Sestamibi scan in the follow-up of differentiated thyroid carcinoma
21. Longterm treatment results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma
22. Detection and treatment of lung metastases of differentiated thyroid carcinoma in patients with normal chest X-Rays
23. Thyroid disease
24. The significance of I-131 scan dose in patients with thyroid cancer: Determination of ablation: Concise communication